[HTML][HTML] Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
[PDF][PDF] Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
NK Mishra, C Guda - bioinformatics.com.cn
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
NK Mishra, C Guda - Oncotarget, 2017 - experts.nebraska.edu
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
NK Mishra, C Guda - Oncotarget, 2017 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
NK Mishra, C Guda - Oncotarget, 2017 - europepmc.org
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
[引用][C] Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
NK Mishra, C Guda - Oncotarget, 2017 - cir.nii.ac.jp
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
NK Mishra, C Guda - Oncotarget, 2017 - oncotarget.com
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
[PDF][PDF] Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
NK Mishra, C Guda - 122.112.229.208
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
NK Mishra, C Guda - Oncotarget, 2017 - europepmc.org
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
[PDF][PDF] Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
NK Mishra, C Guda - bioinformatics.com.cn
Pancreatic cancer (PC) is the fourth leading cause of cancer deaths in the United States with
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …
a five-year patient survival rate of only 6%. Early detection and treatment of this disease is …